Guided Relaxation for Sickle Cell Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether guided relaxation can help manage pain and stress in hospitalized adults with sickle cell disease (SCD). Participants will watch short relaxation videos on a tablet to determine if this can complement traditional pain treatments like opioids. The trial also includes a control group where participants discuss their experiences with SCD. Suitable participants should have SCD, have recently experienced significant pain, and be admitted to UF Health for a pain crisis. As an unphased trial, this study offers participants the chance to explore innovative pain management techniques that could enhance their quality of life.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. It focuses on adding guided relaxation as a supplement to existing treatments for pain management in sickle cell disease.
What prior data suggests that this guided relaxation intervention is safe for inpatients with sickle cell disease?
Research has shown that guided relaxation is safe for people with sickle cell disease. Previous studies have explored its use as an easy, non-drug method to manage pain and stress. These studies found no major side effects for those using guided relaxation techniques. This method involves listening to and watching calming audio and video recordings to help reduce pain and stress. Although more remains to be learned about its mechanisms, the evidence so far suggests it is safe for people with sickle cell disease.12345
Why are researchers excited about this trial?
Researchers are excited about the guided relaxation treatment for sickle cell disease because it offers a non-drug approach to managing stress and pain. Unlike the standard care options like pain medications and blood transfusions, guided relaxation uses a soothing audio-visual method to potentially provide immediate relief. This technique is particularly appealing as it empowers patients with a self-administered tool that could reduce reliance on medications and enhance overall well-being.
What evidence suggests that guided relaxation is effective for managing pain and stress in sickle cell disease?
Research has shown that guided relaxation (GR) can reduce pain and stress in people with sickle cell disease (SCD). In this trial, participants will watch a guided relaxation video clip featuring calming scenes as an experimental non-drug method. For individuals with SCD, this approach may lower pain levels and reduce the need for pain medications like opioids. By calming the mind, GR might also manage stress and improve mood. Early evidence suggests that GR offers a simple and affordable way to support other pain treatments for SCD.12367
Who Is on the Research Team?
Miriam Ezenwa, PhD, RN, FAAN
Principal Investigator
University of Florida
Are You a Good Fit for This Trial?
This trial is for adult inpatients at UF Health with sickle cell disease who are experiencing pain, self-identify as African descent or Hispanic, and can speak and read English. It's not suitable for those who are legally blind, physically or cognitively unable to participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants are assigned to either the Guided Relaxation or Attention Control group and receive a 12-minute intervention
Intervention
Participants engage in daily stress/pain tracking and guided relaxation or discussion activities
Follow-up
Participants are monitored for short-term effects on pain and stress
What Are the Treatments Tested in This Trial?
Interventions
- Guided Relaxation video clip
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor